| Product NDC: | 0093-8019 |
| Proprietary Name: | Pramipexole Dihydrochloride |
| Non Proprietary Name: | Pramipexole Dihydrochloride |
| Active Ingredient(s): | .75 mg/1 & nbsp; Pramipexole Dihydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0093-8019 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090241 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101013 |
| Package NDC: | 0093-8019-98 |
| Package Description: | 90 TABLET in 1 BOTTLE (0093-8019-98) |
| NDC Code | 0093-8019-98 |
| Proprietary Name | Pramipexole Dihydrochloride |
| Package Description | 90 TABLET in 1 BOTTLE (0093-8019-98) |
| Product NDC | 0093-8019 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pramipexole Dihydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101013 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | PRAMIPEXOLE DIHYDROCHLORIDE |
| Strength Number | .75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |